Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the official start of the DEFINE GPS study, with the first patient being ...
Randomized controlled trial with up to 3,000 participants at 75 sites to compare outcomes between physiological guidance by iFR data co-registered on the angiogram (interventional X-ray image) versus ...
The two-video course, ``Flying GPS Approaches--Featuring the KLN 89B,'' is designed to introduce pilots to GPS navigation. In Part 1, pilots learn how to go beyond ``direct to'' and use an IFR GPS.
OLATHE, Kan.--(BUSINESS WIRE)--Garmin International Inc., a unit of Garmin Ltd. (NASDAQ: GRMN), the global leader in satellite navigation, today commemorates the twentieth anniversary of the Garmin ...
First patient enrolled in global randomized controlled trial with up to 3,200 participants at 100 sites comparing patient outcomes after percutaneous coronary intervention (PCI) procedures guided by ...
The DEFINE GPS (Distal Evaluation of Functional performance with Intravascular sensors to assess the Narrowing Effect: Guided Physiologic Stenting) study will be the first time that the use of iFR in ...
Philips announces first patient enrollment in DEFINE GPS global multicenter study to assess superiority of PCI procedures guided by co-registered iFR and interventional angiography GlobeNewswire June ...
Royal Philips, a global leader in health technology, announced a new randomized controlled trial to assess patient outcomes after receiving a percutaneous coronary intervention (PCI) guided by Philips ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback